Clinical trial
The Role of FDG PET in Radiation Treatment Planning for Head and Neck Cancers
NCT00230269 · Stanford University, Other · Completed
Key facts
| NCT number | NCT00230269 |
|---|---|
| Title | The Role of FDG PET in Radiation Treatment Planning for Head and Neck Cancers |
| Official title | The Role of FDG PET in Radiation Treatment Planning for Head and Neck Cancers |
| Lead sponsor | Stanford University, Other |
| Collaborators | McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc. Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Head and Neck Cancer |
| Intervention type | Procedure |
| Interventions | PET-CT |
| Enrollment | 5 |
| Start date | May 1, 2003 |
| Primary completion | Jun 1, 2006 |
| Completion | Nov 1, 2007 |
| First posted | Sep 30, 2005 |
| Last update posted | Jul 12, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: